These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2920789)

  • 1. Controlled release of dopamine from a polymeric brain implant: in vitro characterization.
    Freese A; Sabel BA; Saltzman WM; During MJ; Langer R
    Exp Neurol; 1989 Mar; 103(3):234-8. PubMed ID: 2920789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release of dopamine from a polymeric brain implant: in vivo characterization.
    During MJ; Freese A; Sabel BA; Saltzman WM; Deutch A; Roth RH; Langer R
    Ann Neurol; 1989 Apr; 25(4):351-6. PubMed ID: 2634975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer.
    Yang MB; Tamargo RJ; Brem H
    Cancer Res; 1989 Sep; 49(18):5103-7. PubMed ID: 2766281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release of insulin from polymer matrices. In vitro kinetics.
    Brown L; Siemer L; Munoz C; Langer R
    Diabetes; 1986 Jun; 35(6):684-91. PubMed ID: 3519323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed intracranial delivery of a nitric oxide donor from a controlled-release polymer prevents experimental cerebral vasospasm in rabbits.
    Pradilla G; Thai QA; Legnani FG; Hsu W; Kretzer RM; Wang PP; Tamargo RJ
    Neurosurgery; 2004 Dec; 55(6):1393-9; discussion 1399-1400. PubMed ID: 15574221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymers for the controlled release of macromolecules: effect of molecular weight of ethylene-vinyl acetate copolymer.
    Hsu TT; Langer R
    J Biomed Mater Res; 1985 Apr; 19(4):445-60. PubMed ID: 4055827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained and controlled release of neuroactive substances in the CNS by encapsulation into implantable polymers.
    Peterson GM
    Neurobiol Aging; 1989; 10(5):639-40; discussion 648-50. PubMed ID: 2812244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cells and tissue reaction to intraperitoneally implanted polymer capsules.
    Christenson L; Wahlberg L; Aebischer P
    J Biomed Mater Res; 1991 Sep; 25(9):1119-31. PubMed ID: 1778997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatibility of polymeric delivery systems for macromolecules.
    Langer R; Brem H; Tapper D
    J Biomed Mater Res; 1981 Mar; 15(2):267-77. PubMed ID: 7348718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zero-order controlled-release polymer matrices for micro- and macromolecules.
    Hsieh DS; Rhine WD; Langer R
    J Pharm Sci; 1983 Jan; 72(1):17-22. PubMed ID: 6827458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro release of macromolecules from polymeric drug delivery systems.
    Brown LR; Wei CL; Langer R
    J Pharm Sci; 1983 Oct; 72(10):1181-5. PubMed ID: 6644569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer treatment with a locally insertable controlled release delivery system.
    Keskar V; Mohanty PS; Gemeinhart EJ; Gemeinhart RA
    J Control Release; 2006 Oct; 115(3):280-8. PubMed ID: 17034891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of comonomer ratio on hydrocortisone diffusion from sustained-release composite capsules.
    Fu JC; Moyer DL; Hagemeier C
    J Biomed Mater Res; 1978 May; 12(3):249-54. PubMed ID: 670251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate.
    Tallury P; Alimohammadi N; Kalachandra S
    Dent Mater; 2007 Apr; 23(4):404-9. PubMed ID: 16556460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of ethylene vinyl acetate copolymers (EVA) in drug delivery systems.
    Schneider C; Langer R; Loveday D; Hair D
    J Control Release; 2017 Sep; 262():284-295. PubMed ID: 28789964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of controlled-release polymers in the subarachnoid space after subarachnoid hemorrhage in rabbits.
    Pradilla G; Wang PP; Legnani FG; Frazier JL; Tamargo RJ
    J Neurosurg; 2004 Jul; 101(1):99-103. PubMed ID: 15255258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled drug release from polymeric delivery devices IV: in vitro--in vivo correlation of subcutaneous release of norgestomet from hydrophilic implants.
    Chien YW; Lau EP
    J Pharm Sci; 1976 Apr; 65(4):488-92. PubMed ID: 1271244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implant-associated local drug delivery systems based on biodegradable polymers: customized designs for different medical applications.
    Sternberg K; Petersen S; Grabow N; Senz V; Meyer zu Schwabedissen H; Kroemer HK; Schmitz KP
    Biomed Tech (Berl); 2013 Oct; 58(5):417-27. PubMed ID: 23979120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prolonged-release drug formulations for parenteral administration. Part II. Microspheres and implants for injection].
    Płaczek M; Jacyna J; Sznitowska M
    Pol Merkur Lekarski; 2014 Jan; 36(211):54-8. PubMed ID: 24645581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External control of drug release. IV. Controlled release of 5-fluorouracil from a hydrophilic polymer matrix by microwave irradiation.
    Miyazaki S; Yokouchi C; Takada M
    Chem Pharm Bull (Tokyo); 1989 Jan; 37(1):208-10. PubMed ID: 2720851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.